Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis

Fig. 6

Predicting the Impact of ANXA5 Expression on Immunotherapy Response in Gastric Cancer Patients. (A) Analyzing the correlation between ANXA5 and the expression of immune-related genes in 17 public datasets; (B) Assessing the correlation between ANXA5 expression and the response to anti-PD-1/CTLA-4 therapy in the Riaz cohort 2018; (C-G) Evaluating the diagnostic performance of ANXA5 expression in predicting immunotherapy response in five cohorts

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us